Noticias de AZN_US
Noticias del mercado
Últimas noticias sobre AZN_US — 625 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
AstraZeneca completed its ZEGFROVY licensing deal with Dizal, gaining global rights to develop and commercialize the EGFR lung cancer treatment.
AstraZeneca stock trades softer on September 1, 2026, as investors digest a fresh Zegfrovy agreement
Daiichi Sankyo and AstraZeneca received EU approval for Enhertu plus pertuzumab after Phase 3 data showed improved progression-free survival.
AstraZeneca stock holds in the mid-$160s as a fresh FY2026 EPS estimate cut and solid quarterly resu
AstraZeneca stock trades steadily as investors weigh strong Q2 2026 results and positive Tezspire Ph
AstraZeneca stock is drawing attention after August 30, 2026 heart failure data and a July 27, 2026
AstraZeneca stock is in focus as new ESC Congress 2026 data show its oral relaxin agonist AZD5462 im
AstraZeneca stock is steady after a July 27, 2026 earnings update showed $15.38 billion in quarterly
Página 2 de 32